| First Author | Matesanz N | Year | 2018 |
| Journal | PLoS Biol | Volume | 16 |
| Issue | 7 | Pages | e2004455 |
| PubMed ID | 29979672 | Mgi Jnum | J:263689 |
| Mgi Id | MGI:6192135 | Doi | 10.1371/journal.pbio.2004455 |
| Citation | Matesanz N, et al. (2018) p38alpha blocks brown adipose tissue thermogenesis through p38delta inhibition. PLoS Biol 16(7):e2004455 |
| abstractText | Adipose tissue has emerged as an important regulator of whole-body metabolism, and its capacity to dissipate energy in the form of heat has acquired a special relevance in recent years as potential treatment for obesity. In this context, the p38MAPK pathway has arisen as a key player in the thermogenic program because it is required for the activation of brown adipose tissue (BAT) thermogenesis and participates also in the transformation of white adipose tissue (WAT) into BAT-like depot called beige/brite tissue. Here, using mice that are deficient in p38alpha specifically in adipose tissue (p38alphaFab-KO), we unexpectedly found that lack of p38alpha protected against high-fat diet (HFD)-induced obesity. We also showed that p38alphaFab-KO mice presented higher energy expenditure due to increased BAT thermogenesis. Mechanistically, we found that lack of p38alpha resulted in the activation of the related protein kinase family member p38delta. Our results showed that p38delta is activated in BAT by cold exposure, and lack of this kinase specifically in adipose tissue (p38delta Fab-KO) resulted in overweight together with reduced energy expenditure and lower body and skin surface temperature in the BAT region. These observations indicate that p38alpha probably blocks BAT thermogenesis through p38delta inhibition. Consistent with the results obtained in animals, p38alpha was reduced in visceral and subcutaneous adipose tissue of subjects with obesity and was inversely correlated with body mass index (BMI). Altogether, we have elucidated a mechanism implicated in physiological BAT activation that has potential clinical implications for the treatment of obesity and related diseases such as diabetes. |
